期刊文献+

川崎病281例临床分析 被引量:9

Clinical analysis of 281 cases of Kawasaki disease
在线阅读 下载PDF
导出
摘要 目的探讨川崎病(KD)的临床特征、实验室检查、冠脉损害的相关因素及治疗。方法对南京市儿童医院2005年3月至2009年2月诊治的281例KD患儿的病历资料进行回顾性分析和总结。结果 281例KD中不完全性KD 53例(18.9%),对静脉丙种球蛋白(IVIG)治疗无反应的KD 12例(4.27%),男性191例,女性90例,男女比例约为2.1∶1。年龄最小2个月,最大13岁。<1岁87例,1~3岁121例,3~5岁42例,>5岁31例。平均发病年龄2岁3个月。急性期合并损害冠脉者74例(26.3%),其中冠脉扩张41例(14.6%),小冠脉瘤26例(9.3%),中等冠脉瘤7例(2.5%)。住院2周后新发生的冠脉扩张22例(10.6%)。冠脉损害者随访6个月至3年,完全恢复正常者67例,其中1例对IVIG治疗无反应患儿,住院2周后出现巨大冠状动脉瘤,随访2年完全恢复正常。结论川崎病冠脉损伤与发热持续时间、血红蛋白(Hb)、血小板(PLT)、血沉(ESR)有关。KD发病10 d内用IVIG效果好,2 g/kg单次注射优于1 g/(kg.d)连用2 d的疗法。 Objective To investigate the clinical features,laboratory examination,risk factors of coronary artery lesions and treatment for Kawasaki disease(KD).Methods A total of 281 patient with KD hospitalized in Nanjing Children’s Hospital during March 2005 and February 2009 were reviewed.Results Among 281 cases,53 cases(18.9%) were diagnosed with incomplete KD;12 cases(4.27 %) were diagnosed IVIG refractory KD;191 cases were male and 90 were female,male to female ratio being 2.1:1.The age was from 2 months to 13 years old.87 cases were under 1 year old,121 from 1 to 3 years old,42 from 3 to 5 years old and 31 over 5 years old.The mean age was 2 years and 3 months.A total of 74 cases were complicated with CAL(26.3%),including 41 coronary artery dilations(14.6%),26 small coronary artery aneurysms(9.3%) and 7 medium coronary artery aneurysms(2.5%).Two weeks after intravenous IVIG treatment,the new cases of coronary abnormalities were 22/207(10.6%).The patients with CAL were followed up from 6 months to 3 years,67 cases regressed completely.Among these 1 incomplete KD case occurred giant coronary artery aneurysm at two weeks after hospitalization.Followed up for two years,this patient was regressed normal completely.Conclusion The risk factors of CAL include persistent fever,low hemoglobin,high platelet,and high erythrocyte sedimentation rate(ESR).Children receiving IVIG 2g/kg in the early 10 days of KD have little chance of CAL.The single dose of 2g/kg IVIG administration has better effect than twice of 1g/kg.
出处 《安徽医学》 2012年第1期29-32,共4页 Anhui Medical Journal
关键词 川崎病 不完全川崎病 冠脉损害 丙种球蛋白 Kawasaki disease Incomplete Kawasaki disease Coronary artery lesion Gamma globulin
  • 相关文献

参考文献10

二级参考文献70

  • 1陈兆鸿,吕淑泓,刘特长.静脉注射丙种球蛋白治疗川崎病的疗效及优选剂量探讨[J].中国心血管杂志,2005,10(5):356-358. 被引量:16
  • 2金兰中,李国敏,马桂琴,朱家莱.川崎病的超声心动图检查[J].中华心血管病杂志,1996,24(1):38-40. 被引量:26
  • 3黄国英,马晓静,黄敏,陈树宝,黄美蓉,邱定忠,过仲珍,蒋瑾瑾,周晓迅,于清,桂永浩,宁寿葆,张拓红,杜忠东,Hiroshi Yanagawa,Tomisaku Kawasaki.上海地区1998-2002年川崎病流行病学特征[J].中国循证儿科杂志,2006,1(1):8-13. 被引量:63
  • 4覃丽君,王宏伟,胡秀芬,刘清军,施虹,隈远祥,陈全景,程佩萱.静脉注射不同剂量丙种球蛋白治疗川崎病的临床研究[J].中华儿科杂志,2006,44(12):891-895. 被引量:40
  • 5王慕逖.儿科学[M].人民卫生出版社,2001,11,第五版.282-283.
  • 6胡亚美 江载芳.诸福棠实用儿科学[M](第7版)[M].北京:人民卫生出版社,2002.1199-1201.
  • 7Hashino K, Ishii M, Iemura M, et al. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int, 2001,43:211-217.
  • 8Wright DA, Newburger JW, Baker A, et al. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr,1996,128:146-149.
  • 9Wallace CA, French JW, Kahn SJ, et al. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics, 2000,105:E78.
  • 10Brogan PA, Bose A, Burgner D, et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child, 2002,86:286-290.

共引文献160

同被引文献78

  • 1张伟,李秋,赵晓东,唐雪梅,王晓刚,王墨,吴道奇,欧茜,杨锡强.川崎病发生冠状动脉病变危险因素的Logistic回归分析[J].中国实用儿科杂志,2006,21(1):51-53. 被引量:40
  • 2覃丽君,王宏伟,程佩萱.川崎病诊治及随访的若干问题研究进展[J].实用儿科临床杂志,2006,21(9):557-558. 被引量:3
  • 3张永兰,杜忠东.小儿川崎病冠状动脉损伤的危险因素[J].中国实用儿科杂志,2006,21(10):742-744. 被引量:48
  • 4胡亚美,江载方.诸福堂实用儿科学[M].第7版.北京:人民卫生出版社,2003:802-810.
  • 5胡亚美 江载芳.诸福棠实用儿科学[M]第7版[M].北京:人民卫生出版社,2002.1514.
  • 6无,赵晓东(整理),杜忠东(整理).川崎病专题讨论会纪要[J].中华儿科杂志,2007,45(11):826-830. 被引量:149
  • 7Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association [J]. Circulation, 2004, 110(17) : 2747-2771.
  • 8Shulman ST, Rowley AH. Advances in Kawasaki disease [ J] Eur J pediatr, 2004, 163(6) : 285-291.
  • 9Newburger JW. Kawasaki disease: who is at risk [ Jl ? J Pediatr 2000, 137(2): 149-152.
  • 10Honkanen VE, McCrindle BW, Laxer RM, et al. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease [J].Pediatr Cardiol, 2003, 24(2) : 122-126.

引证文献9

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部